- Home
- TRVI vs BWMX Comparison
TRVI vs BWMX Comparison
Compare TRVI & BWMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRVI
- BWMX
- Stock Information
- Founded
- TRVI 2011
- BWMX 1995
- Country
- TRVI United States
- BWMX Mexico
- Employees
- TRVI N/A
- BWMX N/A
- Industry
- TRVI Biotechnology: Pharmaceutical Preparations
- BWMX Catalog/Specialty Distribution
- Sector
- TRVI Health Care
- BWMX Consumer Discretionary
- Exchange
- TRVI Nasdaq
- BWMX Nasdaq
- Market Cap
- TRVI 383.4M
- BWMX 447.8M
- IPO Year
- TRVI 2019
- BWMX N/A
- Fundamental
- Price
- TRVI $6.07
- BWMX $10.27
- Analyst Decision
- TRVI Strong Buy
- BWMX Strong Buy
- Analyst Count
- TRVI 8
- BWMX 1
- Target Price
- TRVI $17.56
- BWMX $22.50
- AVG Volume (30 Days)
- TRVI 1.6M
- BWMX 24.0K
- Earning Date
- TRVI 05-06-2025
- BWMX 04-24-2025
- Dividend Yield
- TRVI N/A
- BWMX 13.56%
- EPS Growth
- TRVI N/A
- BWMX N/A
- EPS
- TRVI N/A
- BWMX 0.92
- Revenue
- TRVI N/A
- BWMX $676,704,288.00
- Revenue This Year
- TRVI N/A
- BWMX $8.79
- Revenue Next Year
- TRVI N/A
- BWMX $6.14
- P/E Ratio
- TRVI N/A
- BWMX $11.22
- Revenue Growth
- TRVI N/A
- BWMX 8.39
- 52 Week Low
- TRVI $2.30
- BWMX $10.02
- 52 Week High
- TRVI $7.39
- BWMX $20.36
- Technical
- Relative Strength Index (RSI)
- TRVI 54.54
- BWMX 38.96
- Support Level
- TRVI $4.85
- BWMX $10.02
- Resistance Level
- TRVI $6.15
- BWMX $11.31
- Average True Range (ATR)
- TRVI 0.50
- BWMX 0.63
- MACD
- TRVI -0.04
- BWMX -0.10
- Stochastic Oscillator
- TRVI 73.94
- BWMX 13.69
About TRVI Trevi Therapeutics Inc.
Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.
About BWMX Betterware de Mexico S.A.P.I. de C.V.
Betterware de Mexico SAPI de CV is a direct-to-consumer selling company. The company operates through two business segments: the home organization products (Betterware segment or BWM segment) and the beauty and personal care products (B and PC) (JAFRA segment). The Betterware's segment is divided into different categories based on the type of products it sells and includes, kitchen and food preservation, home solutions, bathroom, laundry & cleaning, tech and mobility, and bedroom and wellness products. The JAFRA's segment is divided into fragrance, color, skincare, and toiletries products. The company generates a majority of its revenue from the Beauty and personal care (B&PC) (JAFRA segment). Geographically, key revenue for the company is derived from Mexico.